Investors
News
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 4, 2024
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
March 15, 2024
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 8, 2024
Delcath Systems to Participate in Upcoming Investor Conferences
March 8, 2024
Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System)
February 22, 2024
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
Disclaimer
You are about to review presentations, reports, filings and/or other materials regarding Delcath Systems, Inc. (NASDAQ: DCTH) that contain time-sensitive information. The information contained therein is only current as of the date thereof. Delcath expressly disclaims any obligation to review, update or correct these materials after the date thereof. Delcath may update, amend, supplement or otherwise alter the information contained in any such materials by subsequent presentations, reports, filings, or other means without notice. Certain statements made on this Web site or in materials accessed in or through this section of our Web site are “forward–looking statements,” which are subject to risks and uncertainties, and Delcath’s actual results may differ (possibly materially) from those indicated in such statements. Data Provided by Thomson Reuters.